The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Nov. 16

Monday, November 16, 2020 12:00 – 1:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing […]

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Nov. 19

Thursday, November 19, 2020 4:00 – 6:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing […]

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that […]

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with […]

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES RELEASE DATE: NOVEMEBER 11, 2020 VALID FOR CREDIT THROUGH: OCTOBER 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use […]

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited by the Consortium of Multiple Sclerosis Centers (CMSC) and Haymarket Medical Education (HME). Supported by an educational grant from Bristol Myers Squibb. Intended Audience Neurologists and other physicians, nurse practitioners, PAs, registered nurses, and pharmacists who collaborate to provide care for patients with MS Program […]

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

Thursday, November 12, 2020 8:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing treatment for […]

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October 21, 2021 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and CMEology. This activity is supported by educational grants from Biogen, Bristol Myers Squibb, and EMD Serono. Target Audience This activity is designed to meet the educational needs of neurologists, […]

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October 31, 2021 Target Audience The target audience for this activity is nursing professionals involved in the management of patients with MS. Learning Objectives At the conclusion of this activity, learners should be better able to: Incorporate accumulated evidence, current guidelines, and emerging new clinical data […]

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

Release Date: July 31, 2020 Valid for Credit Through: July 31, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported in part by independent education grants from Alexion Pharmaceuticals and Genentech. Credit Available Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™ Nurses — 1.25 Nursing Contact Hours Pharmacists — 1.25 Contact […]